Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantation
β Scribed by Raymond Wong; Munir Shahjahan; Xuemei Wang; Peter F. Thall; Marcos de Lima; Issa Khouri; James Gajewski; Jorge Alamo; Daniel Couriel; Borje S. Andersson; Michelle Donato; Chitra Hosing; Krishna Komanduri; Paolo Anderlini; Jeffrey Molldrem; Naoto T. Ueno; Elihu Estey; Cindy Ippoliti; Richard Champlin; Sergio Giralt
- Book ID
- 116277935
- Publisher
- Elsevier Science
- Year
- 2005
- Tongue
- English
- Weight
- 183 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1083-8791
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract In this uniβcentre retrospective study, we studied 120 adults with acute myeloid leukaemia (AML) (__n__β=β88) and myelodysplastic syndrome (MDS) (__n__β=β32) who received first allogeneic HSCT to determine prognostic factors which are correlated with the outcome after myeloablative (MA)